320 related articles for article (PubMed ID: 23418481)
1. Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia.
Li L; Voullaire L; Sandi C; Pook MA; Ioannou PA; Delatycki MB; Sarsero JP
PLoS One; 2013; 8(2):e55940. PubMed ID: 23418481
[TBL] [Abstract][Full Text] [Related]
2. A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.
Lufino MM; Silva AM; Németh AH; Alegre-Abarrategui J; Russell AJ; Wade-Martins R
Hum Mol Genet; 2013 Dec; 22(25):5173-87. PubMed ID: 23943791
[TBL] [Abstract][Full Text] [Related]
3. Rescue of the Friedreich ataxia knockout mutation in transgenic mice containing an FXN-EGFP genomic reporter.
Sarsero JP; Holloway TP; Li L; Finkelstein DI; Ioannou PA
PLoS One; 2014; 9(3):e93307. PubMed ID: 24667739
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
[TBL] [Abstract][Full Text] [Related]
5. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
[TBL] [Abstract][Full Text] [Related]
6. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
Vilema-Enríquez G; Quinlan R; Kilfeather P; Mazzone R; Saqlain S; Del Molino Del Barrio I; Donato A; Corda G; Li F; Vedadi M; Németh AH; Brennan PE; Wade-Martins R
J Biol Chem; 2020 Dec; 295(52):17973-17985. PubMed ID: 33028632
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.
Sarsero JP; Holloway TP; Li L; McLenachan S; Fowler KJ; Bertoncello I; Voullaire L; Gazeas S; Ioannou PA
Mamm Genome; 2005 Apr; 16(4):228-41. PubMed ID: 15965784
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A).
Ahmad I; Kamai A; Zahra S; Kapoor H; Kumar Srivastava A; Faruq M
Stem Cell Res; 2024 Jun; 77():103382. PubMed ID: 38484450
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
Liu J; Verma PJ; Evans-Galea MV; Delatycki MB; Michalska A; Leung J; Crombie D; Sarsero JP; Williamson R; Dottori M; Pébay A
Stem Cell Rev Rep; 2011 Sep; 7(3):703-13. PubMed ID: 21181307
[TBL] [Abstract][Full Text] [Related]
13. Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion.
Shen X; Kilikevicius A; O'Reilly D; Prakash TP; Damha MJ; Rigo F; Corey DR
Bioorg Med Chem Lett; 2018 Sep; 28(17):2850-2855. PubMed ID: 30076049
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.
Hackett PT; Jia X; Li L; Ward DM
J Biol Chem; 2022 Jun; 298(6):101982. PubMed ID: 35472330
[TBL] [Abstract][Full Text] [Related]
15. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
[TBL] [Abstract][Full Text] [Related]
16. Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.
Calmels N; Seznec H; Villa P; Reutenauer L; Hibert M; Haiech J; Rustin P; Koenig M; Puccio H
BMC Neurol; 2009 Aug; 9():46. PubMed ID: 19703283
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
[TBL] [Abstract][Full Text] [Related]
19. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
[TBL] [Abstract][Full Text] [Related]
20. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
Polak U; Li Y; Butler JS; Napierala M
Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
